Innovative Hypertension Treatment: Baxdrostat's Role and Risks

Created using ChatSlide

The BaxHTN trial investigates baxdrostat's efficacy and safety as a treatment for resistant hypertension, highlighting its role as an aldosterone synthase inhibitor. This presentation covers the trial's purpose, highlighting mechanisms differing from current mineralocorticoid receptor antagonists (MRAs), and its 12-week placebo-controlled design showing notable reductions in systolic blood pressure. Despite its promise, concerns such as dose-dependent hyperkalemia and kidney function at...